Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis.

MLA

Solomon, Scott D., et al. “Combined Neprilysin and Renin-Angiotensin System Inhibition in Heart Failure with Reduced Ejection Fraction: A Meta-Analysis.” European Journal of Heart Failure, vol. 18, no. 10, Oct. 2016, pp. 1238–43. EBSCOhost, https://doi.org/10.1002/ejhf.603.

APA

Solomon, S. D., Claggett, B., McMurray, J. J. V., Hernandez, A. F., & Fonarow, G. C. (2016). Combined neprilysin and renin-angiotensin system inhibition in heart failure with reduced ejection fraction: a meta-analysis. European Journal of Heart Failure, 18(10), 1238–1243. https://doi.org/10.1002/ejhf.603

Chicago

Solomon, Scott D., Brian Claggett, John J.V. McMurray, Adrian F. Hernandez, and Gregg C. Fonarow. 2016. “Combined Neprilysin and Renin-Angiotensin System Inhibition in Heart Failure with Reduced Ejection Fraction: A Meta-Analysis.” European Journal of Heart Failure 18 (10): 1238–43. doi:10.1002/ejhf.603.